SCP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.730800E-01
Normal-vs-Stage2
5.413600E-01
Normal-vs-Stage3
6.202200E-01
Normal-vs-Stage4
3.438600E-01
Stage1-vs-Stage2
8.861600E-01
Stage1-vs-Stage3
4.047400E-01
Stage1-vs-Stage4
4.575600E-01
Stage2-vs-Stage3
2.054800E-01
Stage2-vs-Stage4
4.175000E-01
Stage3-vs-Stage4
1.743830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.151200E-01
Normal-vs-AfricanAmerican
3.181000E-01
Normal-vs-Asian
5.738800E-01
Caucasian-vs-AfricanAmerican
2.218200E-01
Caucasian-vs-Asian
5.517200E-01
AfricanAmerican-vs-Asian
6.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.800400E-01
Normal-vs-Female
4.669200E-01
Male-vs-Female
7.755600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.094200E-01
Normal-vs-Age(41-60Yrs)
3.502800E-01
Normal-vs-Age(61-80Yrs)
6.807800E-01
Normal-vs-Age(81-100Yrs)
5.888600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.021600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.591400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.395800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.585900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.534800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.778400E-01
Normal-vs-Daily Drinker
8.258800E-01
Normal-vs-Weekly Drinker
5.823200E-01
Normal-vs-Occasional Drinker
2.200000E-01
Normal-vs-Social Drinker
7.824000E-01
Non Drinker-vs-Daily Drinker
5.494200E-01
Non Drinker-vs-Weekly Drinker
5.141700E-02
Non Drinker-vs-Occasional Drinker
9.614400E-02
Non Drinker-vs-Social Drinker
5.346600E-01
Daily Drinker-vs-Weekly Drinker
2.358800E-01
Daily Drinker-vs-Occasional Drinker
5.591800E-02
Daily Drinker-vs-Social Drinker
9.854000E-01
Weekly Drinker-vs-Occasional Drinker
2.645000E-03
Weekly Drinker-vs-Social Drinker
1.677970E-01
Occasional Drinker-vs-Social Drinker
4.843900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.034810E-01
Normal-vs-Grade 2
1.662350E-02
Normal-vs-Grade 3
2.498300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.208210E-01
Grade 1-vs-Grade 3
5.443000E-01
Grade 1-vs-Grade 4
1.034810E-01
Grade 2-vs-Grade 3
2.652600E-01
Grade 2-vs-Grade 4
1.662350E-02
Grade 3-vs-Grade 4
2.498300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.474800E-01
Normal-vs-NonDiabetic
6.039600E-01
Diabetic-vs-NonDiabetic
3.931000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.461600E-01
Normal-vs-NoPancreatitis
6.274600E-01
Pancreatitis-vs-NoPancreatitis
4.137200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.922600E-01
Normal-vs-N1
5.416600E-01
N0-vs-N1
8.814600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.401000E-01
Normal-vs-TP53-NonMutant
6.461000E-01
TP53-Mutant-vs-TP53-NonMutant
1.299380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
